Target intelligence / Profile preview

Apoptosis-enhancing nuclease (AEN)

Target
AEN
Molecular classification
Enzyme, Exonuclease, Nuclear protein, Other
01

Overview

Apoptosis-enhancing nuclease (AEN) is a nuclear exonuclease that acts on both single- and double-stranded DNA and RNA and is directly induced by the tumor suppressor protein p53 following DNA damage[1][3]. It contains conserved exonuclease domains and translocates from the nucleolus to the nucleoplasm during apoptosis, promoting DNA fragmentation and contributing to the execution phase of p53-dependent apoptosis[1]. AEN also participates in regulating autophagic processes under genotoxic stress and can decrease clonogenic survival independent of classical apoptosis pathways[2]. Its function links p53 signaling, apoptosis, and autophagy—processes relevant for tumor suppression and genotoxic stress responses[1][2][3].

Other names
ISG20L1SBBI58FLJ12484FLJ12562Interferon-stimulated 20 kDa exonuclease-like 1pp12744apoptosis-enhancing nucleaseinterferon-stimulated exonuclease gene 20kDa-like 1
02

Mechanism of action

Induction of apoptosis through DNA and RNA degradation in a p53-dependent manner, modulation of autophagy

03

Biological functions

ApoptosisDNA degradationp53-dependent cell deathRNA degradationAutophagyGene regulationCell death
04

Disease associations

CancerOther
05

Safety considerations

Potential induction of cell death in non-target cells if overexpressedimportance in p53-dependent pathways means off-target effects could influence tumor suppression or normal tissue apoptosis

Beyond the preview

Go deeper on Apoptosis-enhancing nuclease (AEN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apoptosis-enhancing nuclease (AEN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call